Showing 931-940 of 10590 results for "".
Rethinking Schizophrenia Treatment Through Muscarinic Modulation
https://reachmd.com/programs/cme/rethinking-schizophrenia-treatment-through-muscarinic-modulation/37103/Learn expert insights on muscarinic antipsychotics in schizophrenia, including mechanisms, safety, and switching considerations.CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
https://reachmd.com/programs/cme/cdh6-in-focus-advancing-biomarker-driven-strategies-for-platinum-resistant-ovarian-cancer/36229/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerNavigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
https://reachmd.com/programs/cme/navigating-the-therapeutic-landscape-of-platinum-resistant-ovarian-cancer/37667/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerMOA: CDH6-Targeted Antibody-Drug Conjugates
https://reachmd.com/programs/cme/MOA-cdh6-targeted-antibody-drug-conjugates/37668/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerClinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
https://reachmd.com/programs/cme/clinical-evidence-insights-from-early-trials-of-cdh6-targeted-therapies/37669/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerShifting the Script: Personalizing Overactive Bladder Treatment in Complex Patients
https://reachmd.com/programs/cme/shifting-the-script-personalizing-overactive-bladder-treatment-in-complex-patients/54125/Examine strategies to personalize overactive bladder management, including in patients with BPH, with attention to β₃-agonists and APP-led care pathways.ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
https://reachmd.com/programs/cme/adcs-across-the-spectrum-of-her2-expression-in-metastatic-breast-cancer/32202/Dr. Reshma Mahtani presents patient case challenges highlighting the use of antibody-drug conjugates in HER2-expressing metastatic breast cancer.Collaborative Care for CRSwNP Expert and Patient Insights
https://reachmd.com/programs/cme/collaborative-care-for-crswnp-expert-and-patient-insights/36695/Chronic rhinosinusitis with nasal polyps (CRSwNP) presents a large burden on more than 3 million patients with the conditions — especially when intertwined with asthma and allergy. Join our discussion between patients with CRSwNP and leading experts in ENT, allergy, and pulmonary medicine as they:Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
https://reachmd.com/programs/cme/breaking-ground-2025-milestones-in-cushing-syndrome-and-looking-forward-to-2026/50059/2025 delivered an expanded approval for Cushing syndrome for one agent, a complete response letter for another, and deeper insights on the prevalence of Cushing syndrome (or hypercortisolism) in people with difficult-to-control metabolic conditions. 2026 promises to be jam packed with further insighHER2-Expressing MBC In Depth: The Latest Advances in Targeted Therapies and Brain Metastases Management
https://reachmd.com/programs/cme/her2-expressing-mbc-in-depth-the-latest-advances-in-targeted-therapies-and-brain-metastases-management/29733/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.